It also addresses the FDA’s communications Using the applicant, the retention of records that assistance the SE report, confidentiality of the SE report, how an applicant can amend or withdraw an SE report, how an applicant may perhaps transfer possession of the SE report back to a brand new applicant and electronic submission from the SE report